Educational Articles

Loading...
Accelerate your knowledge of stocks, funds, options, convertibles and the economy.  Get the most from Value Line research through must-read articles that make you a smarter investor.


Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Second Quarter 2018

7/31/2018 12:13:10 PM New York-based drugmaker and Dow-30 component Pfizer (PFE) reported second-quarter earnings of $0.65 a share, versus $0.51 in the comparable period of 2017. The year-over-year improvement was driven primarily by reduced taxes (-12%) and higher revenues (+4%), partially offset by increased costs tied to production (+10%) and SG&A (+3%).
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer First Quarter 2018

5/1/2018 12:01:19 PM New York-based drugmaker and Dow-30 component Pfizer (PFE) reported first-quarter earnings of $0.59 a share, versus $0.51 in the comparable period of 2017. The year-over-year improvement was driven primarily by reduced taxes, lower restructuring charges, and a modest top-line advance (+1%), partially offset by increased production (+4%), SG&A (+3%), and research & development (+2%) costs.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Fourth Quarter 2017

1/30/2018 12:03:36 PM Drugmaker and Dow-30 component Pfizer reported better-than-expected December-quarter earnings, but the stock pulled back 2% following the release.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Third Quarter 2017

10/31/2017 11:13:03 AM Drugmaker and Dow-30 component Pfizer reported better-than-expected September-quarter earnings, but the stock pulled back slightly following the release.
read more

Daily Updates/ Markets

Stock Market Today: October 30, 2017

10/30/2017 9:12:26 AM The stock market kicked off the new trading week with an uninspiring performance. At the close of the day, the Dow Jones Industrial Average was down roughly 85 points; the broader S&P 500 Index was off eight points; and the NASDAQ was lower by two points. Meanwhile, market breadth showed a negative bias to the session, as decliners easily outpaced advancers on the NYSE. Most of the major equity sectors lost ground, with considerable declines in the industrial, healthcare, and consumer names. In contrast, energy stocks forged ahead. Technology issues also made progress.
read more

Daily Updates/ Market Daily Updates

Stock Market Today: October 11, 2017

10/11/2017 8:50:06 AM The stock market got off to a tentative start this morning, but managed to shape up nicely as the session progressed. At the close of trading, the Dow Jones Industrial Average was up 42 points; the broader S&P 500 Index was ahead nearly five points; and the NASDAQ was higher by 16 points.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer Second Quarter 2017

8/1/2017 1:21:02 PM New York-based drugmaker and Dow-30 component Pfizer (PFE) has reported second-quarter earnings of $0.51 a share, versus $0.33 in the comparable period of 2016. The year-over-year improvement was driven primarily by a sharp decline in production costs (-16%), which more than offset a 2% pullback in sales.
read more

Highlights/ StockHighlights

Dow 30 Earnings: Pfizer First Quarter 2017

5/2/2017 1:00:40 PM New York-based drugmaker and Dow-30 component Pfizer (PFE) has reported first-quarter earnings of $0.51 a share, versus $0.49 in the comparable period of 2016. The bottom-line improvement was fueled primarily by reduced production costs (-13%) and, to a lesser extent, lower SG&A (-2%) and R&D (-1%) outlays, which helped mitigate a 2% year-over-year dip in sales. Meantime, adjusted earnings, which excluded one-time gains, charges, and other nonrecurring items, and are more closely followed by Wall Street, came in at $0.69 a share, versus $0.67 in 2016.
read more

Daily Updates/ Market Daily Updates

Stock Market Today: May 2, 2017

5/2/2017 8:54:40 AM The stock market put in another mixed session today, as traders digested the latest batch of corporate earnings reports and speculated about the Federal Reserve’s next move. At the close of trading, the Dow Jones Industrial Average was ahead 34 points, while the broader S&P 500 Index was up slightly, and the NASDAQ was ahead modestly, as well.
read more

PAGE
OF 12